BRIEF published on 12/11/2025 at 19:28, 5 months 12 days ago Danone : Mise à jour sur les droits de vote et actions Droits De Vote Actions AMF Transparence Danone
PRESS RELEASE published on 12/11/2025 at 19:23, 5 months 12 days ago Danone: Information on the total number of voting rights and shares French company DANONE provides details on voting rights and shares. Total shares: 681,394,483. Total voting rights: 721,569,060 (theoretical), 684,158,643 (exercisable) Voting Rights French Company Shares AMF Danone
PRESS RELEASE published on 12/11/2025 at 19:23, 5 months 12 days ago DANONE : Informations relatives au nombre total de droits de vote et d’actions Informations sur le nombre total de droits de vote et d’actions de DANONE conformément aux réglementations de l'AMF. Droits De Vote Actions AMF Informations Financières Danone
BRIEF published on 10/28/2025 at 07:35, 6 months 26 days ago Danone Reports Strong Q3 Growth Driven by Volume/Mix Sales Growth Regional Performance 2025 Financial Guidance Danone Q3 2025 Volume/Mix Impact
BRIEF published on 10/28/2025 at 07:35, 6 months 26 days ago Danone annonce une forte croissance au troisième trimestre, tirée par le volume et le mix Croissance Des Ventes Performance Régionale Orientations Financières 2025 Danone T3 2025 Impact Du Volume/mix
PRESS RELEASE published on 10/28/2025 at 07:30, 6 months 26 days ago Danone: Strong and consistent growth in Q3, led by volume/mix Danone reports strong and consistent growth in Q3 2025, led by volume/mix. Sales reach €6,876m, up +4.8% on a like-for-like basis. 2025 guidance confirmed, aiming for +3% to +5% sales growth Sales Growth Danone 2025 Guidance Q3 2025 Volume/mix
PRESS RELEASE published on 10/28/2025 at 07:30, 6 months 26 days ago DANONE : Poursuite de la forte croissance au troisième trimestre, tirée par le volume/mix Danone annonce une croissance de +4,8% au T3 2025, tirée par le volume/mix. Objectifs 2025 confirmés. Analyse par zone géographique et catégorie Croissance Objectifs 2025 Danone T3 2025 Volume/mix
BRIEF published on 10/07/2025 at 18:24, 7 months 16 days ago Danone annonce une mise à jour des droits de vote et des actions Actions AMF Actionnariat Droit De Vote Danone
BRIEF published on 10/07/2025 at 18:24, 7 months 16 days ago Danone Announces Voting Rights and Shares Update Voting Rights Shares AMF Shareholding Danone
PRESS RELEASE published on 10/07/2025 at 18:19, 7 months 16 days ago Danone: Information on the total number of voting rights and shares Danone, a French Société anonyme, discloses information on total shares and voting rights in compliance with French regulations Voting Rights Shares Regulations French Danone
Published on 05/23/2026 at 19:45, 8 hours 47 minutes ago Golden Minerals Announces Closing of Equity Financing
Published on 05/23/2026 at 03:15, 1 day 1 hour ago UraniumX Approved for Trading on the OTCQB Venture Market and Announces Board Change
Published on 05/23/2026 at 03:00, 1 day 1 hour ago Battery X Metals Reports Up to ~84 km Estimated Driving Range Increase Across Multiple BYD Electric Vehicles Following Next-Generation Patent-Pending Lithium-Ion Battery Rebalancing Trials, Demonstrating Performance Improvement Across the World’s Larges
Published on 05/23/2026 at 02:25, 1 day 2 hours ago Battery X Metals Announces up to $2 Million Private Placement Financing and Initiative to Strengthen Balance Sheet
Published on 05/23/2026 at 02:25, 1 day 2 hours ago Bolt Metals Completes 402 line-km MobileMT Survey at Northwind Property, Quebec
Published on 05/23/2026 at 16:30, 12 hours 1 minute ago HiFS 2026: Upgrading Four Major Digital Finance Solutions to Accelerate Financial Institutions Toward Agentic Banking
Published on 05/23/2026 at 15:57, 12 hours 35 minutes ago EQS-Adhoc: Delivery Hero confirms approach by Uber Technologies’ with respect to potential takeover offer
Published on 05/22/2026 at 22:05, 1 day 6 hours ago Abivax présente ses résultats financiers du T1 2026 et les données à trois ans de l’étude 108, un essai d’extension ouvert de phase 2a/2b évaluant l’obéfazimod après réduction de dose dans la RCH
Published on 05/22/2026 at 22:05, 1 day 6 hours ago Abivax Presents Q1 2026 Financial Results and Reports Three-Year Interim Data from Study 108, a Phase 2a/2b Open-Label Extension Trial of Obefazimod Following Dose De-Escalation in Patients with UC
Published on 05/22/2026 at 19:51, 1 day 8 hours ago Turkiye Garanti Bankasi A.S.: Brokerage Houses Warrants Redemption Prices
Published on 05/22/2026 at 19:35, 1 day 8 hours ago PROJET D'EVOLUTION DE SA GOUVERNANCE ET LA NOMINATION D'UN PRESIDENT DU DIRECTOIRE PAR INTERIM
Published on 05/22/2026 at 18:05, 1 day 10 hours ago Déclaration hebdomadaire d'opérations effectuées du 18 au 22 mai 2026
Published on 05/22/2026 at 18:05, 1 day 10 hours ago Disclosure of transactions in own shares from May 18 to May 22, 2026
Published on 05/22/2026 at 12:52, 1 day 15 hours ago Communiqué du Conseil d’administration – Assemblée Générale du 22 mai 2026
Published on 05/22/2026 at 12:52, 1 day 15 hours ago Release from the Board of Directors - Shareholders’ Meeting of May 22, 2026
